Allen Andrew R

CIK 00013745397 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001374539

Recent Transactions

50 trades

Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2026-06-16+21,781→ 21,781 total
Award
Cullinan Therapeutics, Inc.$CGEM
Stock Option (Right to Buy)
2025-08-07+79,456→ 79,456 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2024-07-01+660,000→ 660,000 total
Gift
Gritstone bio, Inc.
Common Stock
2024-06-24−325,000→ 985,360 total
Gift
Gritstone bio, Inc.
Common Stock
2024-06-24−325,000→ 1,124,275 total
Sale
Gritstone bio, Inc.
Common Stock
2024-05-16$0.75/sh−24,263→ 985,360 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2024-05-15+615,000→ 615,000 total
Award
Gritstone bio, Inc.
Common Stock
2024-05-15+47,873→ 1,009,623 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2024-02-01+615,000→ 615,000 total
Award
Gritstone bio, Inc.
Common Stock
2024-02-01+105,000→ 899,345 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+73,212→ 73,212 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+152,376→ 152,376 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+109,746→ 109,746 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+45,348→ 45,348 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+109,746→ 109,746 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to Purchase Ordinary Shares
2023-07-05+56,868→ 56,868 total
Award
Adaptimmune Therapeutics PLC$ADAP
Option to purchase Ordinary Shares
2023-07-03+500,000→ 500,000 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−12,100→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−8,072→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−12,100→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−16,800→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−5,000→ 0 total
Disposition to Issuer
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2023-06-01−6,270→ 0 total
Award
Gritstone bio, Inc.
Common Stock
2023-02-02+738,550→ 856,750 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2022-12-15+16,800→ 16,800 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−6,000→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−1,250→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Common Stock
2022-07-01$55.00/sh−1,650→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−750→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−12,030→ 0 total
Disposition to Issuer
Sierra Oncology, Inc.
Stock Option (right to buy)
2022-07-01−625→ 0 total
Award
Gritstone bio, Inc.
Common Stock
2022-01-31+70,000→ 118,200 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2022-01-31+410,000→ 410,000 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2021-12-09+12,100→ 12,100 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2021-06-11+40,559→ 40,559 total
Award
Epizyme, Inc.
Common Stock, par value $0.0001
2021-06-11+8,060→ 20,560 total
Award
Sierra Oncology, Inc.
Stock Option (Right To Buy)
2021-06-08+6,000→ 6,000 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2021-03-08+290,000→ 290,000 total
Award
Gritstone bio, Inc.
Common Stock
2021-01-07+48,200→ 48,200 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2020-12-10+12,100→ 12,100 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2020-06-09+12,030→ 12,030 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2020-05-29+14,013→ 14,013 total
Exercise/Conversion
Epizyme, Inc.
Stock Option (Right to Buy)
2020-03-16−12,500→ 0 total
Exercise/Conversion
Epizyme, Inc.
Common Stock
2020-03-16$9.33/sh+12,500→ 12,500 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2020-02-25+275,000→ 275,000 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-12-19−5,000→ 5,000 total
Award
Sierra Oncology, Inc.
Stock Option (right to buy)
2019-06-11+30,000→ 30,000 total
Award
Epizyme, Inc.
Stock Option (Right to Buy)
2019-05-31+17,633→ 17,633 total
Award
TCR2 THERAPEUTICS INC.
Stock Option (Right to Buy)
2019-04-11+6,270→ 6,270 total
Award
Gritstone bio, Inc.
Stock Option (Right to Buy)
2019-02-13+180,000→ 180,000 total

Companies

Recent Filings

Address

C/O CULLINAN THERAPEUTICS, INC. ONE MAIN STREET, SUITE 1350

CAMBRIDGE, MA, 02142

View on SEC.gov